Pune, India-based Zensar Technologies, an RPG Group Company, announced the complete acquisition of BridgeView Life Sciences LLC, a Pennsylvania-based information technology and operations services firm, in the life sciences sector, in an all-cash deal valued at $14 million. This strategic move aims to strengthen Zensar's Healthcare and Life Sciences (HLS)...
Dr. Reddy’s Lab Acquires U.S. Generic Prescription Portfolio from Mayne Pharma
Hyderabad, India-headquartered Dr. Reddy's Laboratories Ltd.'s wholly owned subsidiary, Dr. Reddy's Laboratories SA, announced the acquisition of the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Limited. The U.S. generic prescription portfolio includes approximately 45 commercial products, four pipeline products, and 40 approved non-marketed products, including a number...
India’s Glenmark Gets USFDA Approval for Generic Diabetes Medication
Mumbai headquartered Glenmark Pharmaceuticals Ltd announced that its U.S. subsidiary Glenmark Pharmaceuticals Inc, USA, received the second tentative approval from the United States Food and Drug Administration to market a generic medication to treat diabetes in the American market. The drug is Saxagliptin, which is the generic version of Onglyza...
Aurobindo Pharma Gets USFDA Nod for Prostate Cancer Drug
Hyderabad, India-based Aurobindo Pharma announced that its wholly owned subsidiary Eugia Pharma Specialties, received a final approval from the U.S. Food & Drug Administration to manufacture and market Leuprolide Acetate Injection. Injectables This drug is used in palliative treatment of advance prostatic cancer. It had an estimated market size of $83...
India’s Eugia Pharma Gets USFDA Approval to Make and Market Prostate Cancer Drug
Hyderabad, India-headquartered Aurobindo Pharma announced that its wholly- owned subsidiary Eugia Pharma Specialties, received final approval from the U.S. Food & Drug Administration to manufacture and market Leuprolide Acetate injection, 14 mg/2.8 mL MDV (Kit). This drug is indicated for the palliative treatment of advanced prostate cancer. The product is...
India Regulator to Review Stent Price Controls
In July 2016, the Government of India decided to cap the prices of drug-eluting and bare-metal stents, and in February 2017, the ceiling price of bare metal stents was set at $108, while the price of drug-eluting stents was set at $442 before taxes, which for some products was a...